Taipei, Taiwan

Tsung-Lin Li

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Tsung-Lin Li

Introduction

Tsung-Lin Li is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic compounds. With a total of 5 patents to his name, his work has had a substantial impact on medical science.

Latest Patents

Among his latest patents are innovative glycopeptide antibiotic compounds and methods for producing them. One notable patent describes a teicoplanin derivative that is useful for treating infectious diseases. This compound has a specific structure that includes various chemical components, making it a valuable asset in the fight against bacterial infections. Another patent focuses on teicoplanin analogs, which are compounds that inhibit bacterial growth and can be used in pharmaceutical compositions for treating and preventing bacterial infections.

Career Highlights

Tsung-Lin Li has worked with esteemed organizations such as Academia Sinica and Asustek Computer Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Tsung-Lin Li has collaborated with notable colleagues, including Yu-Chen Liu and Syue-Yi Lyu. These partnerships have fostered a rich environment for innovation and development in antibiotic research.

Conclusion

Tsung-Lin Li's contributions to the field of pharmaceuticals, particularly in antibiotic development, highlight his role as a significant inventor. His patents and collaborations reflect a commitment to advancing medical science and improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…